Home
About
Overview
Sharing Data
ORCID
Help
History (2)
CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.
Inhibition of the serum-dependent, amiloride-sensitive sodium transport pathway in human fibroblasts by extracellular divalent cations.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.
CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Cancer. 2005 Sep 01; 104(5):1045-8.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Female
Humans
Male
Melanoma
Middle Aged
Sirolimus
authors with profiles
Thomas Gajewski